Eliseo Albert to Middle Aged
This is a "connection" page, showing publications Eliseo Albert has written about Middle Aged.
Connection Strength
0.122
-
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2021 Mar; 27(3):472.e7-472.e10.
Score: 0.015
-
Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality. J Med Virol. 2021 04; 93(4):1862-1864.
Score: 0.015
-
Amplification of human ß-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens. J Med Virol. 2021 01; 93(1):48-50.
Score: 0.014
-
Kinetics of Alphatorquevirus plasma DNAemia at late times after allogeneic hematopoietic stem cell transplantation. Med Microbiol Immunol. 2019 Apr; 208(2):253-258.
Score: 0.013
-
Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation. J Med Virol. 2018 09; 90(9):1438-1443.
Score: 0.012
-
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients. J Clin Virol. 2017 09; 94:22-28.
Score: 0.012
-
SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers. J Med Virol. 2022 01; 94(1):222-228.
Score: 0.004
-
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients. J Clin Virol. 2021 09; 142:104943.
Score: 0.004
-
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents. Clin Microbiol Infect. 2021 Nov; 27(11):1672-1677.
Score: 0.004
-
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Eur J Clin Microbiol Infect Dis. 2021 Mar; 40(3):485-494.
Score: 0.004
-
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clin Microbiol Infect. 2021 Apr; 27(4):636.e1-636.e4.
Score: 0.004
-
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients. J Clin Virol. 2020 10; 131:104611.
Score: 0.004
-
Caveats in interpreting SARS-CoV-2 IgM+ /IgG- antibody profile in asymptomatic health care workers. J Med Virol. 2021 02; 93(2):634-636.
Score: 0.004
-
Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay. J Med Virol. 2021 02; 93(2):1141-1144.
Score: 0.004
-
SARS-CoV-2-reactive interferon-?-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019. J Med Virol. 2021 01; 93(1):375-382.
Score: 0.004
-
Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2019 May; 38(5):903-912.
Score: 0.003
-
The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Gen Virol. 2017 Oct; 98(10):2530-2542.
Score: 0.003
-
Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017 Aug; 19(4).
Score: 0.003